Enzo Free Cash Flow Operating Cash Flow Ratio from 2010 to 2024

ENZ Stock  USD 1.08  0.05  4.85%   
Enzo Biochem Free Cash Flow Operating Cash Flow Ratio yearly trend continues to be fairly stable with very little volatility. Free Cash Flow Operating Cash Flow Ratio is likely to outpace its year average in 2024. During the period from 2010 to 2024, Enzo Biochem Free Cash Flow Operating Cash Flow Ratio regression line of annual values had r-squared of  0.06 and arithmetic mean of  0.99. View All Fundamentals
 
Free Cash Flow Operating Cash Flow Ratio  
First Reported
2010-12-31
Previous Quarter
1.02075479
Current Value
1.21
Quarterly Volatility
3.89213562
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Enzo Biochem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enzo Biochem's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.5 M, Interest Expense of 187.2 K or Total Revenue of 63.1 M, as well as many indicators such as Price To Sales Ratio of 1.73, Dividend Yield of 2.0E-4 or PTB Ratio of 0.98. Enzo financial statements analysis is a perfect complement when working with Enzo Biochem Valuation or Volatility modules.
  
Check out the analysis of Enzo Biochem Correlation against competitors.
For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.

Latest Enzo Biochem's Free Cash Flow Operating Cash Flow Ratio Growth Pattern

Below is the plot of the Free Cash Flow Operating Cash Flow Ratio of Enzo Biochem over the last few years. It is Enzo Biochem's Free Cash Flow Operating Cash Flow Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Enzo Biochem's overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow Operating Cash Flow Ratio10 Years Trend
Pretty Stable
   Free Cash Flow Operating Cash Flow Ratio   
       Timeline  

Enzo Free Cash Flow Operating Cash Flow Ratio Regression Statistics

Arithmetic Mean0.99
Geometric Mean1.65
Coefficient Of Variation391.91
Mean Deviation1.75
Median1.21
Standard Deviation3.89
Sample Variance15.15
Range20.0138
R-Value(0.25)
Mean Square Error15.32
R-Squared0.06
Significance0.38
Slope(0.21)
Total Sum of Squares212.08

Enzo Free Cash Flow Operating Cash Flow Ratio History

2023 1.02
2022 1.07
2021 1.21
2020 -10.46
2019 1.13
2018 -0.69
2017 1.69

About Enzo Biochem Financial Statements

Enzo Biochem investors use historical fundamental indicators, such as Enzo Biochem's Free Cash Flow Operating Cash Flow Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Enzo Biochem. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Free Cash Flow Operating Cash Flow Ratio 1.02  1.21 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Enzo Stock Analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.